⌘K
Loading ticker…
Scholar Rock Holding Corporation Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Scholar Rock Holding Corporation Common Stock (SRRK) has a 3-month relative strength percentile of 76 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.6%, relative volume 5.22×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 76, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
SRRK is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 14.6% / 28.5%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
SRRK is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.01% weight, $137M notional. Top 3 carry $338M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.01% | $137M |
| IWMiShares Russell 2000 ETF | 0.15% | $105M |
| XBIState Street SPDR S&P Biotech ETF | 1.30% | $96M |
| VXFVanguard Extended Market ETF | 0.06% | $46M |
| IWOiShares Russell 2000 Growth ETF | 0.26% | $32M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $5M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRRK Jan avg: 0.50% median: -2.96% win: 50% σ: 24.79% n: 4 2022-04-12 → 2026-05-29 | SRRK Feb avg: -5.50% median: -2.01% win: 25% σ: 16.97% n: 4 2022-04-12 → 2026-05-29 | SRRK Mar avg: 0.42% median: 2.14% win: 50% σ: 15.00% n: 4 2022-04-12 → 2026-05-29 | SRRK Apr avg: -15.42% median: -17.40% win: 20% σ: 15.05% n: 5 2022-04-12 → 2026-05-29 | SRRK May avg: -16.03% median: -11.85% win: 20% σ: 16.64% n: 5 2022-04-12 → 2026-05-29 | SRRK Jun avg: 12.43% median: 15.73% win: 75% σ: 17.88% n: 4 2022-04-12 → 2026-05-29 (current) | SRRK Jul avg: 8.18% median: 6.80% win: 75% σ: 12.80% n: 4 2022-04-12 → 2026-05-29 | SRRK Aug avg: 0.04% median: -4.73% win: 50% σ: 15.87% n: 4 2022-04-12 → 2026-05-29 | SRRK Sep avg: -0.78% median: -0.14% win: 50% σ: 16.91% n: 4 2022-04-12 → 2026-05-29 | SRRK Oct avg: 85.27% median: 53.23% win: 75% σ: 118.84% n: 4 2022-04-12 → 2026-05-29 | SRRK Nov avg: 18.93% median: 23.68% win: 75% σ: 31.80% n: 4 2022-04-12 → 2026-05-29 | SRRK Dec avg: 18.52% median: 12.40% win: 75% σ: 21.61% n: 4 2022-04-12 → 2026-05-29 |